As part of our Group’s treasury and cash management, we invest in a biotech and pharma portfolio. Our biotech and pharmaceutical portfolio returns positive social outcomes by spearheading the technological applications and innovation to improve our health.
Achernar invests in businesses devoted to enhancing human life.
Improving health through scientific research and application of the latest development in genomics is at the core for long term economic and human prosperity.
Our portfolio of biotech and pharmaceutical enterprises ensures Achernar’s interests at the forefront of medical innovation.
We support the rise of leaders shaping the face of transformative medicine who conduct groundbreaking research in personalized healthcare, oncology and gene therapy.